Loading live market data…

State Street Health Care Select Sector SPDR ETF

AMEX:XLV

$158.29 USD

-$3.12 (-1.93%)

Volume
11.52M
Average Volume
10.35M
Market Capitalization
$40.71B
P/E Ratio
Dividend Yield
%
Price Target
$
Year High
$165.61
Year Low
$127.96
Day High
Day Low
Payout Ratio
$
Current Ratio
$

Industry, Sector & symbol

Stock Exchange AMEX
CEO
Industry Asset Management
Sector Financial Services
Current Symbol XLV
CUSIP 81369Y209
CIK 0001064641
Web https://www.ssga.com/us/en/institutional/etfs/state-street-health-care-select-sector-spdr-etf-xlv
Phone 1-866-787-2257
Currency USD
Employees None
Country US

Liquidity

Debt-to-Equity Ratio
Payout Ratio
Current Ratio
Quick Ratio
Cash Ratio

Sales & Book Value

Annual Sales $-
Price / Sales
Cash Flow
Price / Cash Flow
Price / Book

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating N/A
Rating Score(0-5) 0
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $
Trailing P/E Ratio
PEG Ratio
P/E Growth
Net Income $-
Net Margin %
Pretax Margin %
Return on Equity %
Return on Assets %

Financials Score

AltmanZ Score
Piotroski Score
Working Capital -
Total Assets -
Ebit -
Market Cap -
Total Liabilities -

Poll Results

About State Street Health Care Select Sector SPDR ETF (AMEX:XLV) Stock

The State Street Health Care Select Sector SPDR ETF (XLV) is designed to reflect, before expenses, the price and yield performance of the Health Care Select Sector Index. This benchmark offers a clear representation of the healthcare industry within the S&P 500. The fund provides focused exposure to companies across diverse healthcare fields, such as pharmaceuticals, medical equipment and supplies, healthcare providers and services, biotechnology, life sciences tools and services, and health technology. It allows investors to make targeted strategic or tactical allocations that are more precise than those offered by traditional style-based investment vehicles. ...

Drug Pipeline Wins State Street Over on Healthcare

2026-07-14 17:18:47

State Street Investment Management is turning positive on healthcare stocks after nearly a year of caution. The firm's Q3 2026 sector outlook upgraded healthcare from neutral to positive.

Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge

2026-07-14 10:56:28

JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure.

Q2 Earnings Preview: Tech & Energy Drive Growth Amid Healthcare Headwinds

2026-07-13 10:02:07

As the Q2 earnings season kicks off, the market is widely anticipating strong results, with the technology and energy sectors expected to lead the charge. Current analyst expectations point to a robust 23.3% earnings growth for the S&P 500, which would mark the second consecutive quarter of over 20% growth, according to FactSet.

Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?

2026-07-11 13:45:01

State Street Health Care Select Sector SPDR ETF offers a lower expense ratio and a higher dividend yield than Invesco Nasdaq Biotechnology ETF Invesco Nasdaq Biotechnology ETF provides concentrated exposure to the biotech industry but has experienced higher volatility and a deeper maximum drawdown State Street Health Care Select Sector SPDR ETF tracks a broader index of 60 healthcare stocks from the S&P 500 compared to the Invesco fund's 253 biotech holdings

Not Just Tech: Invest in Innovation With Healthcare

2026-07-09 16:12:55

Traditionally speaking, folks that have looked to tap into innovation in the AI space have done so through tech exposure, particularly with mega-cap names. This is not a surprise, considering the interplay between these companies and AI innovation.

Stocks Look Shaky, But This Sector is Booming (Biotech)

2026-07-09 14:06:06

Biotechnology stocks like Illumina, Eli Lilly and Exelixis have quietly turned into the new market leaders.

4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues

2026-07-08 09:26:10

COLL, IRWD, AMTB and DUK stand out as defensive stock picks as investors rotate from AI-driven tech amid the ongoing sell-off and seek safer sectors.

Goldman’s Top Strategist Sees a Dangerous Amount of Leverage Piling Up

2026-07-07 14:45:10

Ben Snider, Chief U.S. Equity Strategist at Goldman Sachs, went on CNBC to say something that should register with anyone who has been happily riding this market higher. The character of this market is shifting midyear, and the driver is a substantial increase in a substantial increase in leverage across investor types: retail margin debt,... Goldman's Top Strategist Sees a Dangerous Amount of Leverage Piling Up

Frequently Asked Questions

What is the current State Street Health Care Select Sector SPDR ETF (XLV) stock price?

State Street Health Care Select Sector SPDR ETF(AMEX:XLV) stock price is $158.29 in the last trading session. During the trading session, XLV stock reached the peak price of $165.61 while $127.96 was the lowest point it dropped to. The percentage change in XLV stock occurred in the recent session was --1.93% while the dollar amount for the price change in XLV stock was -$-3.12.

XLV's industry and sector of operation?

The AMEX listed XLV is part of Asset Management industry that operates in the broader Financial Services sector.

Who are the executives of XLV?

|
|
|
|
|

How many employees does XLV have?

Number of XLV employees currently stands at None. XLV operates from 1 Iron Street, Boston, MA 2210, US.

How do I contact XLV?

XLV could be contacted at phone #1-866-787-2257 and can also be accessed through its website. XLV operates from 1 Iron Street, Boston, MA 2210, US.

How many shares of XLV are traded daily?

The average number of XLV shares traded daily for last 3 months was 10.35M.

What is the market cap of XLV currently?

The market value of XLV currently stands at $40.71B with its latest stock price at $158.29